News & Updates

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025 by

The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025 by

The investigational influenza–COVID-19 combination vaccine mRNA-1083 has demonstrated noninferiority to recommended standard-care flu and COVID-19 vaccines, with higher immune responses and an acceptable safety profile in adults at least 50 years of age, according to the results of a phase III trial.

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025 by

The use of methotrexate as a first line of treatment for patients with pulmonary sarcoidosis delivers similar efficacy to prednisone as measured by forced vital capacity after 24 weeks, results of the PREDMETH trial have shown.

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025 by

A novel digital psychological therapy, named Almee, demonstrates efficacy in improving health-related quality of life (HRQOL) in patients with pulmonary fibrosis, irrespective of antifibrotic treatment use, reports a study presented at ATS 2025.

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025 by

Acute respiratory infection caused by respiratory syncytial virus (RSV-ARI) nearly triples the risk of death, particularly among individuals with chronic underlying respiratory conditions, as shown in a nationwide cohort study in Denmark.

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025

Mindfulness programme may benefit COVID survivors

17 Jun 2025 by

A mindfulness-based stress reduction (MBSR) programme may improve functional and psychosocial outcomes in patients with long COVID, a study suggests.

Mindfulness programme may benefit COVID survivors

17 Jun 2025

QEH’s comprehensive heart failure programme reduces mortality and hospitalization

17 Jun 2025 by

Heart failure (HF) has a 5-year mortality rate of >50 percent. Delays in diagnosis and initiation and uptitration of guideline-directed medical therapy (GDMT) remain significant gaps in HF management. In an interview with MIMS Doctor, Consultant Cardiologist Dr Michael Lee, Associate Consultant Cardiologist Dr Esmond Fong, and Cardiac Nurse Consultant Ms Cecilia Chan from the Queen Elizabeth Hospital (QEH) shared a comprehensive inpatient and outpatient HF management programme run by a multidisciplinary team (MDT), which successfully improved hospitalization for HF (HHF)–free survival, reduced length of hospital stay, and improved other functional outcomes in local patients.

QEH’s comprehensive heart failure programme reduces mortality and hospitalization

17 Jun 2025

HK study: Intensive postdischarge treatment improves HF outcomes

17 Jun 2025

The REDUCE-HF ambulatory service model of intensive treatment following hospital discharge from acute heart failure (HF) is shown to improve patients’ outcomes at 3 months.

HK study: Intensive postdischarge treatment improves HF outcomes

17 Jun 2025

Distinct comorbidity clusters in acute HF affect clinical outcomes

17 Jun 2025

A study involving 6,545 patients with acute heart failure (HF) has revealed five distinct groups of naturally clustered comorbidities, with the poorest postdischarge outcomes observed in the group with diabetes and chronic kidney disease (CKD), followed by the metabolic group and the elderly/atrial fibrillation (AF) group.

Distinct comorbidity clusters in acute HF affect clinical outcomes

17 Jun 2025

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

15 Jun 2025

Treatment with steady-state, low-dose morphine does not appear to improve sleep efficiency, sleep-disordered breathing frequency, or next-day alertness but may rather result in hypoventilation during sleep in chronic obstructive pulmonary disease (COPD) patients with chronic breathlessness, according to the results of a randomized, double-anonymized, crossover trial.

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

15 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

First-line methotrexate on par with prednisone for sarcoidosis

First-line methotrexate on par with prednisone for sarcoidosis

Digital therapy improves life quality of patients with pulmonary fibrosis

Digital therapy improves life quality of patients with pulmonary fibrosis

RSV-ARI nearly triples mortality risk in new study

RSV-ARI nearly triples mortality risk in new study

Mindfulness programme may benefit COVID survivors

Mindfulness programme may benefit COVID survivors

QEH’s comprehensive heart failure programme reduces mortality and hospitalization

QEH’s comprehensive heart failure programme reduces mortality and hospitalization

HK study: Intensive postdischarge treatment improves HF outcomes

HK study: Intensive postdischarge treatment improves HF outcomes

Distinct comorbidity clusters in acute HF affect clinical outcomes

Distinct comorbidity clusters in acute HF affect clinical outcomes

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness